Sublobar resection for early-stage lung cancer: the issue of safety margins
Gossot D, Lafouasse C, Kovacs E, Seguin-Givelet A.
Eur J Cardiothorac Surg. 2023 Mar 1;63(3):ezad055
Recommandations pour la prise en charge des pneumothorax spontanés primaires (PSP)
Jouneau S, Ricard JD, Seguin-Givelet A, Bigé N, Contou D, Desmettre T, Hugenschmitt D, Kepka S, Le Gloan K, Maitre B, Mangiapan G, Marchand-Adam S, Mariolo A, Marx T, Messika J, Noël-Savina E, Oberlin M, Palmier L, Perruez M, Pichereau C, Roche N, Garnier M, Martinez M; Sous l’égide de la SPLF, avec la collaboration de la SFMU, SRLF, SFCTCV et SFAR.
Rev Mal Respir. 2023 Mar 2:S0761-8425(23)00043-8
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Merlotti A, Sadacca B, Arribas YA, Ngoma M, Burbage M, Goudot C, Houy A, Rocañín-Arjó A, Lalanne A, Seguin-Givelet A, Lefevre M, Heurtebise-Chrétien S, Baudon B, Oliveira G, Loew D, Carrascal M, Wu CJ, Lantz O, Stern MH, Girard N, Waterfall JJ, Amigorena S.
Sci Immunol. 2023 Feb 3;8(80):eabm6359
Consensus on technical procedures for simulation-based training in thoracic surgery: an international needs assessment (Accès au Résumé)
Haidari TA, Nayahangan LJ, Bjerrum F, Hansen HJ, Konge L, Massard G, Batirel HF, Novoa NM, Milton RS, Petersen RH; Delphi Participants.
Eur J Cardiothorac Surg. 2023 Feb 20:ezad058
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study (accès à l’article).
Mordant P MD, PhD, Brosseau S, Milleron B, Santelmo N, Fraboulet-Moreau S, Besse B, Langlais A, Gossot D, Thomas PA, Pujol JL, Ricordel C, Madelaine J, Lamy R, Audigier-Valette C, Missy P, Blons H, Barlesi F, Westeel V; French Cooperative Thoracic Intergroup (IFCT)
Clin Lung Cancer. 2023 Jan;24(1):1-10
